TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Vaccinkliniken Sverige AB
Closing information (x1000 DKK)
| Closing information | 2025/12 | 2024/12 | 2023/12 |
| Turnover |
3,787
|
4,195 | |
| Financial expenses |
4
|
1 | |
| Earnings before taxes |
427
|
438 | |
| EBITDA |
436
|
451 | |
| Total assets |
1,435
|
1,340 | |
| Current assets |
1,429
|
1,330 | |
| Current liabilities |
231
|
426 | |
| Equity capital |
1,204
|
914 | |
| - share capital |
32
|
34 | |
| Employees (average) |
2
|
2
|
5 |
Financial ratios
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Solvency |
83.9%
|
68.2% | |
| Turnover per employee |
1,894
|
839 | |
| Profit as a percentage of turnover |
11.3%
|
10.4% | |
| Return on assets (ROA) |
30.0%
|
32.8% | |
| Current ratio |
618.6%
|
312.2% | |
| Return on equity (ROE) |
35.5%
|
47.9% | |
| Change turnover |
-270
|
-1,306 | |
| Change turnover % |
15%
|
-7%
|
-24% |
| Chg. No. of employees |
0
|
-3
|
-2 |
| Chg. No. of employees % |
0%
|
-60%
|
-29% |
Total value of public sale
| Fiscal year | 2025/12 | 2024/12 | 2023/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.